Max Perutz Labs Vienna
Anna Philina Fabing is a skilled research technician and lab manager currently working at Max Perutz Labs Vienna since January 2024, focusing on molecular control of embryonic cell fate commitment. Prior experience includes a Master’s research internship at Aarhus University investigating α-synuclein aggregation in Parkinson's disease, with expertise in techniques such as proximity ligation assay and immunohistochemistry. Additional research internships were completed at Universität Salzburg, Paracelsus Medizinische Privatuniversität, Vetmeduni Vienna, and Allgemeines Krankenhaus der Stadt Wien, covering diverse topics in molecular regenerative medicine, stress physiology, and immunology. Anna Philina Fabing holds a BSc in Biomedicine & Biotechnology from Vetmeduni and has furthered education at the University of Vienna and Paris Lodron Universität Salzburg.
This person is not in any offices
Max Perutz Labs Vienna
The Max Perutz Labs are a joint venture between the University of Vienna and the Medical University of Vienna that builds on the unique opportunities that arise from being embedded in the Vienna BioCenter Campus while having one of the largest hospitals in Europe, the Vienna General Hospital, on our doorstep. In visualizing haemoglobin, Max Perutz paved the way towards the era of precision medicine. To realize its full potential, precision medicine necessitates a molecular mechanistic approach. Research at the Max Perutz Labs is curiosity-driven and spans the fields of molecular and cell biology. Most groups investigate basic research questions but a significant number are also active in more applied fields of biology. The Max Perutz Labs seek to educate students to think critically and analytically, challenge them to set ambitious goals, and instill in them both broad horizons and deep understanding. In doing so, we aspire to furnish them with the necessary knowledge and skills to push forward the frontiers of 21st century biomedical science.